Linked Life Data

A pilot study to assess smokeless tobacco use reduction with varenicline.

Source:http://linkedlifedata.com/resource/pubmed/id/20724382

Download in:

View as

General Info

Authors

Schroeder DR, Ebbert JO, Croghan IT, North F

Affiliation

Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. ebbert.jon@mayo.edu

Abstract

Long-term smokeless tobacco (ST) use is known to increase the risk for oropharyngeal cancer, heart attack, and stroke. Extant literature on cigarette smokers suggests that smoking reduction increases smoking abstinence among smokers not interested in quitting. Similarly, a reduction strategy may reduce ST exposure and increase ST abstinence rates among ST users not interested in quitting.

PMID
20724382

Publication types

Clinical Trial; Research Support, N.I.H., Extramural